Report Detail

Other Global Brain Tumor Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3412672
  • |
  • 11 July, 2019
  • |
  • Global
  • |
  • 95 pages
  • |
  • QYResearch
  • |
  • Other

Global Brain Tumor Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Brain Tumor Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Surgery
      • 1.4.3 Radiation Therapy
      • 1.4.4 Targeted Therapy
      • 1.4.5 Chemotherapy
      • 1.4.6 Immunotherapy
    • 1.5 Market by Application
      • 1.5.1 Global Brain Tumor Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Oncology Treatment Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Brain Tumor Therapeutics Market Size
    • 2.2 Brain Tumor Therapeutics Growth Trends by Regions
      • 2.2.1 Brain Tumor Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Brain Tumor Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Brain Tumor Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Brain Tumor Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Brain Tumor Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Brain Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Brain Tumor Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Brain Tumor Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Brain Tumor Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Brain Tumor Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Brain Tumor Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Brain Tumor Therapeutics Market Size (2014-2019)
    • 5.2 Brain Tumor Therapeutics Key Players in United States
    • 5.3 United States Brain Tumor Therapeutics Market Size by Type
    • 5.4 United States Brain Tumor Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Brain Tumor Therapeutics Market Size (2014-2019)
    • 6.2 Brain Tumor Therapeutics Key Players in Europe
    • 6.3 Europe Brain Tumor Therapeutics Market Size by Type
    • 6.4 Europe Brain Tumor Therapeutics Market Size by Application

    7 China

    • 7.1 China Brain Tumor Therapeutics Market Size (2014-2019)
    • 7.2 Brain Tumor Therapeutics Key Players in China
    • 7.3 China Brain Tumor Therapeutics Market Size by Type
    • 7.4 China Brain Tumor Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Brain Tumor Therapeutics Market Size (2014-2019)
    • 8.2 Brain Tumor Therapeutics Key Players in Japan
    • 8.3 Japan Brain Tumor Therapeutics Market Size by Type
    • 8.4 Japan Brain Tumor Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Brain Tumor Therapeutics Market Size (2014-2019)
    • 9.2 Brain Tumor Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Brain Tumor Therapeutics Market Size by Type
    • 9.4 Southeast Asia Brain Tumor Therapeutics Market Size by Application

    10 India

    • 10.1 India Brain Tumor Therapeutics Market Size (2014-2019)
    • 10.2 Brain Tumor Therapeutics Key Players in India
    • 10.3 India Brain Tumor Therapeutics Market Size by Type
    • 10.4 India Brain Tumor Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Brain Tumor Therapeutics Market Size (2014-2019)
    • 11.2 Brain Tumor Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Brain Tumor Therapeutics Market Size by Type
    • 11.4 Central & South America Brain Tumor Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Brain Tumor Therapeutics Introduction
      • 12.1.4 Pfizer Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Brain Tumor Therapeutics Introduction
      • 12.2.4 Novartis Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Brain Tumor Therapeutics Introduction
      • 12.3.4 Roche Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Brain Tumor Therapeutics Introduction
      • 12.4.4 Merck Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 AstraZeneca
      • 12.5.1 AstraZeneca Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Brain Tumor Therapeutics Introduction
      • 12.5.4 AstraZeneca Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.5.5 AstraZeneca Recent Development
    • 12.6 GE Healthcare
      • 12.6.1 GE Healthcare Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Brain Tumor Therapeutics Introduction
      • 12.6.4 GE Healthcare Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.6.5 GE Healthcare Recent Development
    • 12.7 Hitachi Medical
      • 12.7.1 Hitachi Medical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Brain Tumor Therapeutics Introduction
      • 12.7.4 Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.7.5 Hitachi Medical Recent Development
    • 12.8 Philips Healthcare
      • 12.8.1 Philips Healthcare Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Brain Tumor Therapeutics Introduction
      • 12.8.4 Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.8.5 Philips Healthcare Recent Development
    • 12.9 Novocure
      • 12.9.1 Novocure Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Brain Tumor Therapeutics Introduction
      • 12.9.4 Novocure Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.9.5 Novocure Recent Development
    • 12.10 DelMar Pharmaceuticals
      • 12.10.1 DelMar Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Brain Tumor Therapeutics Introduction
      • 12.10.4 DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2014-2019)
      • 12.10.5 DelMar Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A brain tumor occurs when abnormal cells form within the brain.
      North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.
      In 2018, the global Brain Tumor Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Brain Tumor Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Tumor Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Novartis
      Roche
      Merck
      AstraZeneca
      GE Healthcare
      Hitachi Medical
      Philips Healthcare
      Novocure
      DelMar Pharmaceuticals

      Market segment by Type, the product can be split into
      Surgery
      Radiation Therapy
      Targeted Therapy
      Chemotherapy
      Immunotherapy

      Market segment by Application, split into
      Hospitals
      Oncology Treatment Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Brain Tumor Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Brain Tumor Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Brain Tumor Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Brain Tumor Therapeutics. Industry analysis & Market Report on Brain Tumor Therapeutics is a syndicated market report, published as Global Brain Tumor Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Brain Tumor Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,202.68
      4,804.02
      6,405.36
      3,516.87
      5,275.30
      7,033.74
      415,334.40
      623,001.60
      830,668.80
      279,789.51
      419,684.26
      559,579.02
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report